{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:28:11Z","timestamp":1793978891784,"version":"4.8.0"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["03-004-2021-T050"],"award-info":[{"award-number":["03-004-2021-T050"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Hartstichting","doi-asserted-by":"publisher","award":["101112022"],"award-info":[{"award-number":["101112022"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013322","name":"European Federation of Pharmaceutical Industries and Associations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013322","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.ijcrp.2026.200641","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T23:44:08Z","timestamp":1777074248000},"page":"200641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Cardiac, oxidative stress, and fibrosis-related biomarkers and new-onset heart failure: Systematic review and meta-analysis"],"prefix":"10.1016","volume":"30","author":[{"given":"Dani\u00eblle J.","family":"Noordermeer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole L.M.","family":"de Kruijf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wichor M.","family":"Bramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemien","family":"van den Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Kavousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.ijcrp.2026.200641_bib1","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.027852","article-title":"Burden, trends, and inequalities of heart failure globally, 1990 to 2019: a secondary analysis based on the global burden of disease 2019 study","volume":"12","author":"Yan","year":"2023","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcrp.2026.200641_bib2","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.15420\/cfr.2023.05","article-title":"Global public health burden of heart failure: an updated review","volume":"9","author":"Shahim","year":"2023","journal-title":"Card. Fail. Rev."},{"issue":"17","key":"10.1016\/j.ijcrp.2026.200641_bib3","doi-asserted-by":"crossref","first-page":"3272","DOI":"10.1093\/cvr\/cvac013","article-title":"Global burden of heart failure: a comprehensive and updated review of epidemiology","volume":"118","author":"Savarese","year":"2023","journal-title":"Cardiovasc. Res."},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200641_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.21037\/cdt-20-302","article-title":"Pathophysiology of heart failure","volume":"11","author":"Schwinger","year":"2021","journal-title":"Cardiovasc. Diagn. Ther."},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200641_bib5","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1161\/HYPERTENSIONAHA.110.156547","article-title":"Hemodynamic determinants of myocardial B-type natriuretic peptide release: relative contributions of systolic and diastolic wall stress","volume":"56","author":"Maeder","year":"2010","journal-title":"Hypertension"},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200641_bib6","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/0006-291X(92)91691-I","article-title":"Concentrations and molecular forms of human brain natriuretic peptide in plasma","volume":"185","author":"Tateyama","year":"1992","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200641_bib7","doi-asserted-by":"crossref","first-page":"446 e5","DOI":"10.1016\/j.amjmed.2015.11.006","article-title":"Clinical characteristics and outcomes of patients with myocardial infarction, myocardial injury, and nonelevated troponins","volume":"129","author":"Sarkisian","year":"2016","journal-title":"Am. J. Med."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200641_bib8","doi-asserted-by":"crossref","first-page":"H2181","DOI":"10.1152\/ajpheart.00554.2011","article-title":"Oxidative stress and heart failure","volume":"301","author":"Tsutsui","year":"2011","journal-title":"Am. J. Physiol. Heart Circ. Physiol."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200641_bib9","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1002\/ejhf.2102","article-title":"Relationship between body mass index, cardiovascular biomarkers and incident heart failure","volume":"23","author":"Suthahar","year":"2021","journal-title":"Eur. J. Heart Fail."},{"issue":"22","key":"10.1016\/j.ijcrp.2026.200641_bib10","doi-asserted-by":"crossref","first-page":"2494","DOI":"10.1001\/jama.2010.1708","article-title":"Association of serial measures of cardiac troponin T using a sensitive assay with incident heart failure and cardiovascular mortality in older adults","volume":"304","author":"deFilippi","year":"2010","journal-title":"JAMA"},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200641_bib11","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1016\/j.ahj.2007.12.031","article-title":"High insulinlike growth factor binding protein 1 level predicts incident congestive heart failure in the elderly","volume":"155","author":"Kaplan","year":"2008","journal-title":"Am. Heart J."},{"issue":"14","key":"10.1016\/j.ijcrp.2026.200641_bib12","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.008108","article-title":"Protein biomarkers of cardiovascular disease and mortality in the community","volume":"7","author":"Ho","year":"2018","journal-title":"J. Am. Heart Assoc."},{"issue":"6","key":"10.1016\/j.ijcrp.2026.200641_bib13","doi-asserted-by":"crossref","first-page":"4151","DOI":"10.1002\/ehf2.13036","article-title":"Proteomic exploration of common pathophysiological pathways in diabetes and cardiovascular disease","volume":"7","author":"Molvin","year":"2020","journal-title":"ESC Heart Fail."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200641_bib14","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1161\/CIRCHEARTFAILURE.114.001185","article-title":"Clinical risk stratification optimizes value of biomarkers to predict new-onset heart failure in a community-based cohort","volume":"7","author":"Brouwers","year":"2014","journal-title":"Circ Heart fail"},{"issue":"18","key":"10.1016\/j.ijcrp.2026.200641_bib15","first-page":"e895","article-title":"2022 AHA\/ACC\/HFSA guideline for the management of heart failure: a report of the American college of cardiology\/american heart association joint committee on clinical practice guidelines","volume":"145","author":"Heidenreich","year":"2022","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200641_bib16","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1001\/jama.2013.7588","article-title":"Natriuretic peptide-based screening and collaborative care for heart failure: the STOP-HF randomized trial","volume":"310","author":"Ledwidge","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/j.ijcrp.2026.200641_bib17","series-title":"Chronic Heart Failure in Adults: Diagnosis and Management (NG106). London","year":"2018"},{"issue":"9","key":"10.1016\/j.ijcrp.2026.200641_bib18","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1373\/clinchem.2014.222778","article-title":"High-sensitivity troponin I and amino-terminal pro--B-type natriuretic peptide predict heart failure and mortality in the general population","volume":"60","author":"McKie","year":"2014","journal-title":"Clin. Chem."},{"issue":"11","key":"10.1016\/j.ijcrp.2026.200641_bib19","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/ejhf.663","article-title":"Biomarker-based risk prediction in the community","volume":"18","author":"AbouEzzeddine","year":"2016","journal-title":"Eur. J. Heart Fail."},{"key":"10.1016\/j.ijcrp.2026.200641_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2022.104170","article-title":"Circulating cardiac biomarkers improve risk stratification for incident cardiovascular disease in community dwelling populations","volume":"82","author":"Wu","year":"2022","journal-title":"EBioMedicine"},{"issue":"8","key":"10.1016\/j.ijcrp.2026.200641_bib21","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.amjcard.2020.01.025","article-title":"N-terminal pro B-type natriuretic peptide and high-sensitivity cardiac troponin as markers for heart failure and cardiovascular disease risks according to glucose status (from the multi-ethnic study of atherosclerosis [MESA])","volume":"125","author":"Nguyen","year":"2020","journal-title":"Am. J. Cardiol."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200641_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090063","article-title":"Comparison of three troponins as predictors of future cardiovascular events--prospective results from the FINRISK and BiomaCaRE studies","volume":"9","author":"Neumann","year":"2014","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200641_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1054\/jcaf.2000.7277","article-title":"Differential responses of circulating and tissue Adrenomedullin and gene expression to volume overload","volume":"6","author":"Hirano","year":"2000","journal-title":"J. Card. Fail."},{"issue":"4","key":"10.1016\/j.ijcrp.2026.200641_bib24","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1093\/cvr\/cvw166","article-title":"The endothelial adrenomedullin-RAMP2 system regulates vascular integrity and suppresses tumour metastasis","volume":"111","author":"Tanaka","year":"2016","journal-title":"Cardiovasc. Res."},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200641_bib25","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1161\/CIRCULATIONAHA.112.000756","article-title":"Vascular endothelial adrenomedullin-RAMP2 system is essential for vascular integrity and organ homeostasis","volume":"127","author":"Koyama","year":"2013","journal-title":"Circulation"},{"issue":"7","key":"10.1016\/j.ijcrp.2026.200641_bib26","doi-asserted-by":"crossref","first-page":"647","DOI":"10.5551\/jat.29967","article-title":"Adrenomedullin-RAMP2 system in vascular endothelial cells","volume":"22","author":"Koyama","year":"2015","journal-title":"J Atheroscler Thromb"},{"issue":"19","key":"10.1016\/j.ijcrp.2026.200641_bib27","doi-asserted-by":"crossref","first-page":"3121","DOI":"10.1161\/01.CIR.0000147181.65298.4D","article-title":"Galectin-3 marks activated macrophages in failure-prone hypertrophied hearts and contributes to cardiac dysfunction","volume":"110","author":"Sharma","year":"2004","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200641_bib28","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/ndt\/gfy006","article-title":"Fibroblast growth factor 23 is induced by an activated renin-angiotensin-aldosterone system in cardiac myocytes and promotes the pro-fibrotic crosstalk between cardiac myocytes and fibroblasts","volume":"33","author":"Leifheit-Nestler","year":"2018","journal-title":"Nephrol. Dial. Transplant."},{"issue":"18","key":"10.1016\/j.ijcrp.2026.200641_bib29","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20184634","article-title":"FGF23-Mediated activation of local RAAS promotes cardiac hypertrophy and fibrosis","volume":"20","author":"Bockmann","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200641_bib30","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1007\/s00467-013-2515-7","article-title":"Associations between fibroblast growth factor 23 and cardiac characteristics in pediatric heart failure","volume":"28","author":"Isakova","year":"2013","journal-title":"Pediatr. Nephrol."},{"issue":"31","key":"10.1016\/j.ijcrp.2026.200641_bib31","doi-asserted-by":"crossref","first-page":"20708","DOI":"10.1074\/jbc.M109.018804","article-title":"Plasminogen activator inhibitor-1 regulates integrin alphavbeta3 expression and autocrine transforming growth factor beta signaling","volume":"284","author":"Pedroja","year":"2009","journal-title":"J. Biol. Chem."},{"issue":"36","key":"10.1016\/j.ijcrp.2026.200641_bib32","doi-asserted-by":"crossref","first-page":"24308","DOI":"10.1074\/jbc.M803341200","article-title":"Transforming growth factor-beta requires its target plasminogen activator inhibitor-1 for cytostatic activity","volume":"283","author":"Kortlever","year":"2008","journal-title":"J. Biol. Chem."},{"issue":"32","key":"10.1016\/j.ijcrp.2026.200641_bib33","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1093\/eurheartj\/eht152","article-title":"Neurohormonal and clinical sex differences in heart failure","volume":"34","author":"Meyer","year":"2013","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200641_bib34","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.jchf.2018.08.008","article-title":"Sex-specific epidemiology of heart failure risk and mortality in Europe: results from the BiomarCaRE consortium","volume":"7","author":"Magnussen","year":"2019","journal-title":"JACC Heart Fail"},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200641_bib35","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018574","article-title":"Sex differences in heart failure with preserved ejection fraction","volume":"10","author":"Sotomi","year":"2021","journal-title":"J. Am. Heart Assoc."},{"issue":"19","key":"10.1016\/j.ijcrp.2026.200641_bib36","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1093\/eurheartj\/eht066","article-title":"Incidence and epidemiology of new onset heart failure with preserved vs. reduced ejection fraction in a community-based cohort: 11-year follow-up of PREVEND","volume":"34","author":"Brouwers","year":"2013","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200641_bib37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1161\/CIRCHEARTFAILURE.112.972828","article-title":"Predictors of new-onset heart failure: differences in preserved versus reduced ejection fraction","volume":"6","author":"Ho","year":"2013","journal-title":"Circ Heart Fail"},{"issue":"1","key":"10.1016\/j.ijcrp.2026.200641_bib38","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/ehf2.14167","article-title":"Biomarker profiles in heart failure with preserved vs. reduced ejection fraction: results from the DIAST-CHF study","volume":"10","author":"Eidizadeh","year":"2023","journal-title":"ESC Heart Fail."},{"issue":"14","key":"10.1016\/j.ijcrp.2026.200641_bib39","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1161\/CIRCULATIONAHA.114.013215","article-title":"Myocardial stiffness in patients with heart failure and a preserved ejection fraction: contributions of collagen and titin","volume":"131","author":"Zile","year":"2015","journal-title":"Circulation"},{"issue":"20","key":"10.1016\/j.ijcrp.2026.200641_bib40","doi-asserted-by":"crossref","first-page":"2138","DOI":"10.1161\/CIRCULATIONAHA.106.632745","article-title":"Impaired chronotropic and vasodilator reserves limit exercise capacity in patients with heart failure and a preserved ejection fraction","volume":"114","author":"Borlaug","year":"2006","journal-title":"Circulation"},{"issue":"10","key":"10.1016\/j.ijcrp.2026.200641_bib41","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1016\/j.jacc.2018.06.050","article-title":"Identifying pathophysiological mechanisms in heart failure with reduced versus preserved ejection fraction","volume":"72","author":"Tromp","year":"2018","journal-title":"J. Am. Coll. Cardiol."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200641_bib42","first-page":"75","article-title":"Treatment of chronic heart failure in the 21st century: a new era of biomedical engineering has come","volume":"5","author":"Hu","year":"2019","journal-title":"Chronic Dis Transl Med"},{"issue":"36","key":"10.1016\/j.ijcrp.2026.200641_bib43","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur. Heart J."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200641_bib44","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.114.000936","article-title":"Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis risk in communities study","volume":"3","author":"Lutsey","year":"2014","journal-title":"J. Am. Heart Assoc."},{"issue":"5","key":"10.1016\/j.ijcrp.2026.200641_bib45","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.115.003079","article-title":"Galectin-3 and risk of heart failure and death in blacks and whites","volume":"5","author":"McEvoy","year":"2016","journal-title":"J. Am. Heart Assoc."},{"issue":"16","key":"10.1016\/j.ijcrp.2026.200641_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020196","article-title":"Fibroblast growth factor 23 and incident cardiovascular disease and mortality in middle-aged adults","volume":"10","author":"Paul","year":"2021","journal-title":"J. Am. Heart Assoc."},{"key":"10.1016\/j.ijcrp.2026.200641_bib47","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13643-015-0004-8","article-title":"Quantifying the risk of error when interpreting funnel plots","volume":"4","author":"Simmonds","year":"2015","journal-title":"Syst. Rev."},{"issue":"2","key":"10.1016\/j.ijcrp.2026.200641_bib48","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3349\/ymj.2010.51.2.151","article-title":"Interpretation and use of natriuretic peptides in non-congestive heart failure settings","volume":"51","author":"Tsai","year":"2010","journal-title":"Yonsei Med. J."},{"issue":"3","key":"10.1016\/j.ijcrp.2026.200641_bib49","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1001\/archinte.167.3.276","article-title":"Acute coronary syndrome vs nonspecific troponin elevation: clinical predictors and survival analysis","volume":"167","author":"Alcalai","year":"2007","journal-title":"Arch. Intern. Med."}],"container-title":["International Journal of Cardiology Cardiovascular Risk and Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526000711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772487526000711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:04:26Z","timestamp":1793977466000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772487526000711"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":49,"alternative-id":["S2772487526000711"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200641","relation":{},"ISSN":["2772-4875"],"issn-type":[{"value":"2772-4875","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiac, oxidative stress, and fibrosis-related biomarkers and new-onset heart failure: Systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology Cardiovascular Risk and Prevention","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcrp.2026.200641","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"200641"}}